FDA Approval for Trastuzumab. Use in Cancer. Trastuzumab is approved to be used alone or with other drugs to treat: Adenocarcinoma of the stomach or gastroesophageal ...
Easy to read patient leaflet for trastuzumab. Includes indications, proper use, special instructions, precautions, and possible side effects.
Find information about Herceptin® (trastuzumab), a targeted therapy for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer. Who is Herceptin for?
Trastuzumab (INN; trade names Herclon, Herceptin) is a monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain breast cancers.
Trastuzumab (Herceptin) metastatic breast cancer treatment side effects, drug interaction, and dosage information.
Learn about the prescription medication Herceptin (Trastuzumab), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Trastuzumab is a cancer medication that interferes with the growth and spread of cancer cells in the body. Trastuzumab is used to treat certain types of breast cancer ...
Trade Name: Herceptin ® Drug Type: Trastuzumab is a monoclonal antibody. (For more detail, see "How Trastuzumab Works" section below). What Trastuzumab Is Used For:
Referenced Subgroup Labeling Sections; Trastuzumab: Oncology: ERBB2: HER2 protein overexpression positive: Indications and Usage Warnings and Precautions
Trastuzumab is standard of care in the treatment of human epidermal growth factor receptor (HER)-2 + early and advanced breast cancer. Recently, it has ...